Coyne Medical vs Echelon Health

Two different approaches to comprehensive preventive health screening

If you are looking for an Echelon Health alternative in London, Coyne Medical offers a different approach to comprehensive private health screening.

Echelon places particular emphasis on extensive diagnostic imaging, using CT alongside selected MRI and ultrasound investigations. At Coyne, every screening programme starts with a 90-minute doctor assessment, with testing built around your medical history, family history and individual risk.

Our Complete and Ultimate Health Programmes also include a personal doctor who stays involved throughout the year.

Health screening at Coyne Medical in London

If you are looking for an Echelon Health alternative in London, the important question is not simply which provider performs the greatest number of investigations.

Good screening means choosing tests that are appropriate for your risk, understanding their limitations, acting on important findings and avoiding unnecessary investigations where the evidence does not support them.

Feature Echelon Health Coyne Medical
Core approach Extensive diagnostic imaging and health assessment Doctor-led screening, risk assessment and ongoing prevention
Current pricing Platinum £14,000
Gold £10,000 men / £9,500 women
Advanced £895
Complete Health Programme £5,950
Ultimate Health Programme £7,950
Initial doctor assessment Physician consultation and examination included 90-minute doctor assessment with every screening programme
Cross-sectional imaging Extensive CT imaging alongside selected MRI and ultrasound Whole-body MRI in Complete and Ultimate, with other imaging added according to individual risk
Ionising radiation Several components of the assessment use CT Whole-body MRI itself does not use ionising radiation
Cardiovascular imaging Includes CT calcium scoring and CT coronary angiography in relevant packages Cardiovascular imaging selected according to individual risk rather than applied identically to everyone
ApoB Not listed in Echelon’s published standard blood panel Routinely included
Lipoprotein(a) Not listed in Echelon’s published standard blood panel Routinely included
Standard cholesterol testing Total, LDL and HDL cholesterol listed Lipids interpreted alongside ApoB, Lp(a), blood pressure and wider cardiovascular risk
Body composition Assessment varies by package Bioimpedance in Advanced; MRI body composition in Complete and Ultimate
VO₂ max Not listed as a core component of the Platinum assessment Laboratory VO₂ max included in Complete and Ultimate
Established cancer screening Extensive imaging plus tests selected within the assessment Bowel, cervical and PSA screening offered according to eligibility and individual risk across our programmes
CA125 / CA19-9 / CEA Included in Echelon’s published blood testing Not used as routine general cancer screening tests in otherwise well people
Inherited cancer genetics Not listed as a core component of the standard Platinum assessment Included in Ultimate Health Programme
Pharmacogenomics Not listed as a core component Included in Ultimate Health Programme
Oral health and Oral Genome Not listed as a core component Included in Ultimate Health Programme
Personal doctor throughout the year Not the standard assessment model Included in Complete and Ultimate
Direct personal-doctor email Not the standard assessment model Included in Complete and Ultimate
Scheduled quarterly health check-ins Not the standard assessment model Included in Complete and Ultimate

Comparison checked October 2026. Services and prices can change and should be checked directly with each provider before booking.

Echelon’s strength is the breadth of diagnostic imaging incorporated into its higher-level assessments.

Its published pathways include CT imaging of the chest, heart and abdomen, CT virtual colonoscopy and bone-density imaging, alongside MRI for areas including the brain and, in men, the prostate.

For someone specifically looking for an intensive imaging-led assessment, that approach may be attractive.

Which tests are most likely to improve your health, and what will we actually do differently because of the result?

CT and MRI are not interchangeable. Each has strengths and limitations, and the right test depends on what you are trying to find.

Echelon

Uses extensive CT imaging alongside selected MRI and ultrasound. CT is particularly valuable for areas such as coronary arteries and lung imaging, but it does involve ionising radiation.

Coyne Complete

Uses whole-body MRI as the main broad cross-sectional imaging assessment, without ionising radiation, with further imaging selected according to age and individual risk.

Risk-based imaging

We still use CT when it is the right investigation, for example coronary calcium assessment or lung cancer screening in someone who meets the relevant risk criteria.

One area where our approach is deliberately different is the routine use of tumour-marker blood tests in people without symptoms.

Echelon’s published blood-testing programme includes CA125, CA19-9 and CEA as tumour markers.

These tests can have important roles when doctors are investigating symptoms, supporting a diagnosis or monitoring someone who already has cancer.

That is different from using them as general screening tests in otherwise well people.

Tumour markers are not specific enough to simply mean “cancer present” or “cancer absent”.

They can be normal when a cancer is present and raised for benign reasons when there is no cancer. That can create false reassurance in one direction and unnecessary anxiety, repeat testing, scans or invasive investigation in the other.

For CA125 specifically, large screening trials have not shown a reduction in ovarian-cancer deaths in average-risk asymptomatic women, while false-positive results can lead to unnecessary surgery. Major guidelines therefore recommend against routine ovarian-cancer screening with CA125 in this population.

CEA is also not recommended as a population screening test for colorectal cancer because of false-positive and false-negative results.

As doctors, we are cautious about adding a test simply because it sounds more comprehensive.

We have seen the real consequences of nonspecific tumour-marker results in well people: anxiety and cascades of further investigation that ultimately find no cancer.

We prioritise established cancer screening where there is evidence that finding disease earlier improves outcomes.

Across our health screening programmes, we consider bowel cancer screening, cervical screening and PSA testing according to age and individual risk, with breast screening added where appropriate.

We then personalise screening further according to family history, smoking history, breast density and other relevant risk factors.

Our Ultimate Health Programme also includes inherited cancer genetic testing, allowing us to identify some people at increased lifetime cancer risk before a tumour exists to be detected.

Dr Lucy Hooper and Dr Hugh Coyne, founders of Coyne Medical

Every Coyne screening starts with a 90-minute doctor assessment.

We review your medical history, family history, lifestyle, symptoms, priorities and previous results before interpreting the tests that follow.

With Complete and Ultimate, that relationship then continues throughout the year.

  • One personal doctor brings your results together
  • Direct email access between scheduled reviews
  • Scheduled quarterly health check-ins
  • Your prevention plan reviewed as your health changes
  • Repeat testing arranged where it changes management
  • Medication started or adjusted where appropriate
  • Further investigations and specialist referrals coordinated when needed

If something needs investigating, treating or monitoring, we stay involved.

Some important risks are inherited and will not necessarily produce an abnormal scan or routine blood result today.

Inherited cancer risk

Genetic testing for inherited variants associated with cancers including breast, ovarian, bowel, prostate and pancreatic cancer.

Pharmacogenomics

Genetic information that may help inform how you respond to commonly prescribed medicines now and in the future.

Inflammation & oral health

Oral health assessment and Oral Genome testing considered alongside inflammatory, cardiovascular and metabolic health.

Echelon Health may suit you if…

Your priority is an exceptionally extensive, imaging-led health assessment including CT, MRI and ultrasound investigations within one comprehensive programme.

Coyne Complete Health Programme may suit you if…

You want advanced blood assessment, whole-body MRI, MRI body composition and laboratory VO₂ max together with a personal doctor who stays involved throughout the year.

Coyne Ultimate Health Programme may suit you if…

You want that same year-long doctor relationship plus inherited cancer genetics, pharmacogenomics and deeper oral and inflammatory assessment.

Choose a comprehensive doctor-led health check, or go deeper with advanced imaging, fitness testing, genetics and ongoing personal doctor care.

Yes, although the approaches are different. Echelon places particular emphasis on extensive CT, MRI and ultrasound imaging. Coyne combines advanced screening with evidence-based cancer and cardiovascular risk assessment and, in Complete and Ultimate, a personal doctor who remains involved throughout the year.

Both. Echelon’s published assessments use substantial CT imaging, including chest, cardiac and abdominal imaging, alongside MRI for selected areas such as the brain and prostate. Coyne Complete and Ultimate use whole-body MRI as the main broad cross-sectional imaging assessment, with other imaging selected according to individual risk.

These tumour markers can be useful in particular clinical situations, including investigating symptoms and monitoring known cancers, but they are not sufficiently specific or sensitive to function as simple general cancer screening tests in otherwise well people.

CA125 screening in average-risk asymptomatic women has not been shown to reduce ovarian-cancer mortality and can lead to false positives and unnecessary surgery. CEA is also not recommended as a population screening test for colorectal cancer because of false-positive and false-negative results.

Echelon’s currently published standard blood panel lists total, LDL and HDL cholesterol, but we could not find ApoB or lipoprotein(a) listed. Coyne routinely includes both as part of cardiovascular risk assessment.

Complete is the most useful comparison if you are looking for a deep current-health assessment using advanced blood testing, whole-body MRI, MRI body composition and laboratory VO₂ max. Ultimate adds inherited cancer genetics, pharmacogenomics and oral-health assessment.

Yes. You can book a 30-minute Discovery Call with a Coyne Medical doctor to discuss your health, family history and what you want from screening. The £250 fee is credited against your screening if you proceed within 12 months.